Skip to main content
Observe Medical logo

Observe Medical — Investor Relations & Filings

Ticker · OBSRV ISIN · NO0010865009 LEI · 9845005F38B74FFJ1B65 Euronext Expand Manufacturing
Filings indexed 643 across all filing types
Latest filing 2023-12-06 Regulatory Filings
Country NO Norway
Listing Euronext Expand OBSRV

About Observe Medical

https://observemedical.com/

Observe Medical is a medical technology company that develops, markets, and sells innovative medtech products for the global market. The company is committed to improving patient welfare and outcomes, increasing clinical data accuracy, and promoting positive health economics. It is building a scalable medtech platform that combines a portfolio of proprietary products with strategic partnerships, leveraging its manufacturing, development, regulatory, and commercial capabilities to bring new technologies to market.

Recent filings

Filing Released Lang Actions
Observe Medical - First order to Croatia
Regulatory Filings Classification · 95% confidence The document is a short press release dated December 6, 2023, announcing a specific business event: receiving the first order for products from a distributor in Croatia. This is a general operational update or news item that does not fit the criteria for formal financial reports (10-K, IR, ER), management changes (MANG), or specific regulatory filings (DVA, DIRS, DIV). Since it is a general announcement of business activity that doesn't fit a more specific category like M&A (TAR) or Capital Change (CAP), it falls best under the general regulatory/news announcement category, which is RNS (Regulatory Filings) as the fallback for miscellaneous announcements.
2023-12-06 English
OBSERVE MEDICAL ASA - Last day of trading in subscription rights
Share Issue/Capital Change Classification · 99% confidence The document is an announcement titled "OBSERVE MEDICAL ASA – Last day of trading in subscription rights." It explicitly references a prior Rights Issue, the approval of a Prospectus by the Financial Supervisory Authority of Norway, and provides deadlines for trading subscription rights and the subscription period itself. This content relates directly to a corporate financing activity (a rights issue) and the associated securities offering mechanics. This aligns best with the 'Capital/Financing Update' category (CAP). It is not a full report (10-K, IR), an earnings release (ER), or a general regulatory filing (RNS), as it concerns a specific capital event.
2023-12-06 English
OBSERVE MEDICAL ASA - Last day of trading in subscription rights
Share Issue/Capital Change Classification · 99% confidence The document is an announcement from Observe Medical ASA regarding the last day of trading in subscription rights related to a Rights Issue. It explicitly mentions the approval of a Prospectus by the Financial Supervisory Authority of Norway and details the mechanics and deadlines for the capital raising activity. This content directly relates to fundraising, financing activities, and capital structure changes (Rights Issue). Therefore, the most appropriate classification is Capital/Financing Update (CAP). It is not a full report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2023-12-06 English
Observe Medical - First order to Slovakia
Regulatory Filings Classification · 96% confidence The document is a short press release dated November 29, 2023, announcing a specific business event: receiving the first order for UnoMeter Abdo Pressure products from a distributor in Slovakia. This is a specific operational update, not a comprehensive financial report (like 10-K or IR), a management change (MANG), or a dividend announcement (DIV). It is a general business announcement. Since there is no specific category for 'Business Update' or 'Sales Announcement', and it is not a formal regulatory filing like a Director's Dealing (DIRS) or Major Shareholding (MRQ), the most appropriate fallback category is Regulatory Filings (RNS), which serves as a general category for miscellaneous regulatory/company announcements that don't fit elsewhere, especially short news items.
2023-11-29 English
Observe Medical ASA - Invitation to a Company presentation 4 December 2023
Investor Presentation Classification · 98% confidence The document contains extensive slides detailing company strategy, product updates (UnoMeter, Biim, Sippi), transaction summaries (Convatec), financial forecasts (free cash flow, revenue expectations), and introductions of management. The structure, use of figures, and forward-looking statements are characteristic of an Investor Presentation (IP) or materials presented to shareholders/investors, often preceding or accompanying an AGM, but the content itself is a detailed presentation package rather than a formal regulatory filing like a 10-K or a simple earnings release (ER). Since it is a detailed presentation package focusing on strategy and financials for investors, 'Investor Presentation' (IP) is the most appropriate classification. It is not a short announcement of a report (RPA/RNS), nor is it a transcript (CT) or a formal annual report (10-K).
2023-11-29 English
Observe Medical ASA - Invitation to a Company presentation 4 December 2023
Investor Presentation Classification · 95% confidence The document is titled 'Observe Medical ASA - Invitation to a Company presentation 4 December 2023'. It explicitly invites recipients to a virtual company presentation hosted by an investment bank (SpareBank 1 Markets) on a specific date. This is not a full financial report (like 10-K or IR), nor is it a transcript of an earnings call (CT). It is an announcement about an upcoming event where company information will be shared, which aligns best with an Investor Presentation (IP) announcement or a general meeting invitation. Since it is an invitation to a 'Company presentation' rather than a formal AGM, and it is clearly aimed at investors, 'Investor Presentation' (IP) is the most fitting category, although it could also be seen as a general announcement (RNS). Given the context of a scheduled presentation detailing company information, IP is preferred over the generic RNS.
2023-11-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.